New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma

Overview of attention for article published in Journal of Clinical Oncology, May 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 2,885 followers.

New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma [DIAGNOSIS … http://t.co/i5rG2es2TC

New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma [DI... http://t.co/GZbdeqtiWc JCO

New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma [DIAGNOSIS… http://t.co/Pqxt4cgAhp

(JCO) New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma http://t.co/8DXsw4exQS

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.